John W. Rollins

Array ( [id] => 3809633 [patent_doc_number] => 05709887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Method and composition for treating tumors' [patent_app_type] => 1 [patent_app_number] => 8/466435 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5308 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/709/05709887.pdf [firstpage_image] =>[orig_patent_app_number] => 466435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3691648 [patent_doc_number] => 05618538 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-08 [patent_title] => 'Methods and compositions for isolating taxanes' [patent_app_type] => 1 [patent_app_number] => 8/470746 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16517 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/618/05618538.pdf [firstpage_image] =>[orig_patent_app_number] => 470746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3742928 [patent_doc_number] => 05753790 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Hypoglycemic agent from cryptolepis' [patent_app_type] => 1 [patent_app_number] => 8/472020 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9190 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753790.pdf [firstpage_image] =>[orig_patent_app_number] => 472020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3643520 [patent_doc_number] => 05628999 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Hypoglycemic agent from cryptolepis' [patent_app_type] => 1 [patent_app_number] => 8/470876 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9229 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/628/05628999.pdf [firstpage_image] =>[orig_patent_app_number] => 470876 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726657 [patent_doc_number] => 05635187 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/467035 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14104 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635187.pdf [firstpage_image] =>[orig_patent_app_number] => 467035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3630718 [patent_doc_number] => 05631001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-20 [patent_title] => 'Antimicrobial grapefruit extract' [patent_app_type] => 1 [patent_app_number] => 8/470225 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3910 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/631/05631001.pdf [firstpage_image] =>[orig_patent_app_number] => 470225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661610 [patent_doc_number] => 05648377 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals' [patent_app_type] => 1 [patent_app_number] => 8/463129 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2390 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648377.pdf [firstpage_image] =>[orig_patent_app_number] => 463129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3658286 [patent_doc_number] => 05624672 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/446685 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14082 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624672.pdf [firstpage_image] =>[orig_patent_app_number] => 446685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3552084 [patent_doc_number] => 05571900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-05 [patent_title] => 'Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/462991 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1617 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/571/05571900.pdf [firstpage_image] =>[orig_patent_app_number] => 462991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3694763 [patent_doc_number] => 05650398 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Drug delivery enhancement via modified saponins' [patent_app_type] => 1 [patent_app_number] => 8/459502 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 37 [patent_no_of_words] => 12402 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650398.pdf [firstpage_image] =>[orig_patent_app_number] => 459502 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3714042 [patent_doc_number] => 05616458 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Tripterygium wilfordii hook F extracts and components, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/455906 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 59 [patent_no_of_words] => 25814 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616458.pdf [firstpage_image] =>[orig_patent_app_number] => 455906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660744 [patent_doc_number] => 05624840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-29 [patent_title] => 'Three-dimensional liver cell and tissue culture system' [patent_app_type] => 1 [patent_app_number] => 8/455441 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 13837 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/624/05624840.pdf [firstpage_image] =>[orig_patent_app_number] => 455441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3711898 [patent_doc_number] => 05616324 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Pro-inflammatory composition comprising at least two members of the group consisting of DL. phenylalanine, ruta graveolans and corydalis bulbosda' [patent_app_type] => 1 [patent_app_number] => 8/456091 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1116 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616324.pdf [firstpage_image] =>[orig_patent_app_number] => 456091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624439 [patent_doc_number] => 05620885 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-15 [patent_title] => 'Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/452952 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12603 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/620/05620885.pdf [firstpage_image] =>[orig_patent_app_number] => 452952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586426 [patent_doc_number] => 05567425 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-22 [patent_title] => 'Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/453530 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12935 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/567/05567425.pdf [firstpage_image] =>[orig_patent_app_number] => 453530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3652172 [patent_doc_number] => 05606047 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-25 [patent_title] => 'Chemically-defined non-polymeric valency platform molecules and conjugates thereof' [patent_app_type] => 1 [patent_app_number] => 8/453254 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32746 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 348 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/606/05606047.pdf [firstpage_image] =>[orig_patent_app_number] => 453254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3504214 [patent_doc_number] => 05514560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-05-07 [patent_title] => 'Substrates for .beta.galactosidase' [patent_app_type] => 1 [patent_app_number] => 8/453904 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4036 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/514/05514560.pdf [firstpage_image] =>[orig_patent_app_number] => 453904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726643 [patent_doc_number] => 05635186 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/453396 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12612 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635186.pdf [firstpage_image] =>[orig_patent_app_number] => 453396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3684917 [patent_doc_number] => 05633395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-27 [patent_title] => 'Chemically-defined non-polymeric valency platform molecules and conjugates thereof' [patent_app_type] => 1 [patent_app_number] => 8/453452 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 32669 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/633/05633395.pdf [firstpage_image] =>[orig_patent_app_number] => 453452 [rel_patent_id] =>[rel_patent_doc_number] =>)